IRIS
FURFARO, FEDERICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.060
AS - Asia 3.792
NA - Nord America 3.103
SA - Sud America 782
Continente sconosciuto - Info sul continente non disponibili 239
AF - Africa 114
OC - Oceania 8
Totale 12.098
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.864
RU - Federazione Russa 2.272
SG - Singapore 1.268
CN - Cina 979
IT - Italia 812
BR - Brasile 631
HK - Hong Kong 548
VN - Vietnam 360
BD - Bangladesh 260
FR - Francia 215
DE - Germania 154
SE - Svezia 126
GB - Regno Unito 122
CA - Canada 118
NL - Olanda 90
IN - India 75
FI - Finlandia 67
MX - Messico 56
AR - Argentina 54
PL - Polonia 48
IQ - Iraq 44
JP - Giappone 44
ID - Indonesia 36
ZA - Sudafrica 36
ES - Italia 33
TR - Turchia 32
EG - Egitto 31
AT - Austria 30
EC - Ecuador 29
CO - Colombia 22
MY - Malesia 18
UA - Ucraina 17
NP - Nepal 15
PK - Pakistan 15
PT - Portogallo 13
CL - Cile 12
PY - Paraguay 12
SA - Arabia Saudita 12
JO - Giordania 11
MA - Marocco 11
CR - Costa Rica 10
UZ - Uzbekistan 10
VE - Venezuela 10
HN - Honduras 9
JM - Giamaica 9
TN - Tunisia 9
LU - Lussemburgo 8
AE - Emirati Arabi Uniti 7
AU - Australia 7
BE - Belgio 7
PH - Filippine 7
IR - Iran 6
OM - Oman 6
PE - Perù 6
TW - Taiwan 6
AL - Albania 5
AZ - Azerbaigian 5
DZ - Algeria 5
GT - Guatemala 5
IL - Israele 5
LT - Lituania 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
CH - Svizzera 4
ET - Etiopia 4
GR - Grecia 4
IE - Irlanda 4
KE - Kenya 4
KY - Cayman, isole 4
LB - Libano 4
LY - Libia 4
NI - Nicaragua 4
RO - Romania 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
KW - Kuwait 3
PS - Palestinian Territory 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
BZ - Belize 2
GY - Guiana 2
HU - Ungheria 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
PA - Panama 2
PR - Porto Rico 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TG - Togo 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 11.843
Salva come PNG Salva come JPEG
Città #
Singapore 638
Hong Kong 533
Moscow 477
San Jose 429
Ashburn 403
Dallas 289
Council Bluffs 225
Beijing 186
Hefei 179
New York 174
Lauterbourg 155
Ho Chi Minh City 145
Milan 139
Los Angeles 107
Santa Clara 93
Hanoi 72
Shanghai 70
Munich 67
Lawrence 58
Princeton 58
São Paulo 55
Rome 52
Orem 42
Montreal 40
Helsinki 38
Warsaw 37
Chicago 31
Naples 30
Frankfurt am Main 29
Manchester 25
Tokyo 25
Johannesburg 24
Denver 23
London 23
Mexico City 23
Phoenix 23
Poplar 23
Brooklyn 22
Chennai 22
Toronto 22
Buffalo 21
Stockholm 21
Bologna 18
Da Nang 18
Atlanta 17
Nuremberg 17
Seattle 17
Baghdad 16
Rio de Janeiro 15
Vienna 15
Boston 14
Charlotte 14
Curitiba 14
Mumbai 14
Bari 13
Basra 13
Florence 13
Turku 13
Amsterdam 12
Ankara 12
Brescia 12
Campinas 12
Dhaka 12
Houston 12
Lappeenranta 12
Turin 12
Belo Horizonte 11
Boardman 11
Brasília 11
Memphis 11
Amman 10
Philadelphia 10
Porto Alegre 10
Quito 10
Tashkent 10
Guayaquil 9
Kuala Lumpur 9
Querétaro 9
Slough 9
Chengdu 8
Esch-sur-Alzette 8
Falkenstein 8
Guangzhou 8
Haiphong 8
Hyderabad 8
Istanbul 8
Las Vegas 8
Ninh Bình 8
Cairo 7
Cape Town 7
Figino 7
Hải Dương 7
Kathmandu 7
Kingston 7
Riyadh 7
Salvador 7
Shenzhen 7
Sorocaba 7
Spokane 7
Washington 7
Totale 5.771
Salva come PNG Salva come JPEG
Nome #
Predictive value of Milan ultrasound criteria in ulcerative colitis: A prospective observational cohort study 309
Fecal, Blood, and Urinary Biomarkers in Inflammatory Bowel Diseases 262
Predictive Value of Bowel Ultrasound in Crohn's Disease: A 12-Month Prospective Study 166
Extraintestinal Manifestations in Inflammatory Bowel Disease: From Pathophysiology to Treatment 158
Advancing Therapeutic Targets in IBD: Emerging Goals and Precision Medicine Approaches 150
Histological Scores in Patients with Inflammatory Bowel Diseases: The State of the Art 133
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 125
Ulcerative colitis : current pharmacotherapy and future directions 124
Endoscopic Treatment Approaches for Inflammatory Bowel Diseases: Old Friends and New Weapons 123
A Comprehensive Multidisciplinary Approach to Diagnosing Chronic Inflammatory Bowel Diseases: Integration of Clinical, Endoscopic, and Imaging Modalities 123
Gut Microbiota Metabolites: Unveiling Their Role in Inflammatory Bowel Diseases and Fibrosis 121
Unlocking hope: The future of ustekinumab biosimilars in Crohn's disease treatment 121
Ulcerative colitis: Impact of early disease clearance on long-term outcomes - A multicenter cohort study 121
Advancing Colorectal Cancer Prevention in Inflammatory Bowel Disease (IBD): Challenges and Innovations in Endoscopic Surveillance 120
Gastrointestinal Ultrasound in Infectious Diseases: A Comprehensive Review 120
Bowel ultrasound score is accurate in assessing response to therapy in patients with Crohn's disease 115
Efficacy and Safety of S1P1 Receptor Modulator Drugs for Patients with Moderate-to-Severe Ulcerative Colitis 115
The role of filgotinib in ulcerative colitis and Crohn's disease 113
Bowel ultrasound in inflammatory bowel disease: How far in the grayscale? 111
Inflammatory Bowel Disease and Colorectal Cancer 111
The Role of IL-23 Inhibitors in Crohn’s Disease 109
Accuracy of Information given by ChatGPT for patients with Inflammatory Bowel Disease in relation to ECCO Guidelines 107
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials 104
Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis 102
Accuracy of Humanitas Ultrasound Criteria in Assessing Disease Activity and Severity in Ulcerative Colitis: A Prospective Study 101
Effect of mesenteric sparing or extended resection in primary ileocolic resection for Crohn's disease on postoperative endoscopic recurrence (SPICY): an international, randomised controlled trial 100
Advances in pharmacotherapy for ulcerative colitis: a focus on JAK1 inhibitors 99
The Role of Vitamin D in Inflammatory Bowel Diseases: From Deficiency to Targeted Therapeutics and Precise Nutrition Strategies 98
Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era 97
Long-term outcome of inflammatory bowel diseases with cytomegalovirus colitis : effect of antiviral treatment 97
Role of Probiotics in the Management of Patients with Ulcerative Colitis and Pouchitis 96
Multiple Ileal and Colonic Stenoses: Is It Always Crohn’s Disease? 95
Targeting mucosal healing in Crohn’s disease: efficacy of novel pathways and therapeutic targets 95
An international multicentre study of SwiTching from Intravenous to subcutaneous inflixiMab and vEdolizumab in inflammatory bowel diseases: The TIME study 93
Carcinomas in inflammatory bowel disease: a narrative review on diagnostic imaging techniques 93
The Role of Fecal Microbiota Transplantation in IBD 91
Prevalence, characteristics, management, and outcomes of difficult-to-treat inflammatory bowel disease 91
New Technologies in Digestive Endoscopy for Ulcerative Colitis Patients 91
Small Bowel Cancer in Crohn’s Disease 91
P139 The learning curve of intestinal ultrasonography in assessing inflammatory bowel disease : preliminary results 90
Leaving behind the Mucosa: Advances and Future Directions of Intestinal Ultrasound in Ulcerative Colitis 89
Evolution and New Horizons of Endoscopy in Inflammatory Bowel Diseases 88
Neutrophil-only Histological Assessment of Ulcerative Colitis Correlates with Endoscopic Activity and Predicts Long-Term Outcomes in a Multicentre Study 87
y ANTIBODIES TO INFLIXIMAB IN PATIENTS TREATED WITH EITHER THE REFERENCE BIOLOGIC OR THE BIOSIMILAR CT-P13 SHOW IDENTICAL REACTIVITY TOWARDS BIOSIMILARS CT-P13 AND SB2 IN INFLAMMATORY BOWEL DISEASE 84
Application of Ultrasound Elastography for Assessing Intestinal Fibrosis in Inflammatory Bowel Disease: Fiction or Reality? 82
Ultrasound remission after biologic induction and long-term endoscopic remission in Crohn's disease: a prospective cohort study 82
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 82
Artificial Endoscopy and Inflammatory Bowel Disease: Welcome to the Future 81
Raising the bar in ulcerative colitis management 78
Epidemiological features and disease-related concerns of a large cohort of Italian patients with active Crohn's disease 78
Colorectal Cancer Surveillance in Patients with Inflammatory Bowel Diseases: Chromoendoscopy or Non-Chromoendoscopy, That Is the Question 77
Gut and mesenteric lymph node involvement in pediatric patients infected with human immunodeficiency virus 77
Early Biological Therapy in Operated Crohn's Disease Patients Is Associated With a Lower Rate of Endoscopic Recurrence and Improved Long-term Outcomes: A Single-center Experience 77
The Management of Postoperative Recurrence in Crohn’s Disease 77
Inflammatory Bowel Disease Care in the COVID-19 Pandemic Era: The Humanitas, Milan, Experience 77
Transforming Gastrointestinal Diagnosis with Molecular Endoscopy: Challenges and Opportunities 76
Absence of COVID-19 Infection in Patients Accessing IBD Unit at Humanitas, Milan: Implications for Postlockdown Measures 75
Clostridioides difficile infection in hospital and community settings: summary document of a multidisciplinary group 75
Bowel ultrasound is accurate in assessing disease activity in ulcerative colitis 73
Biosimilars of adalimumab: the upcoming challenge in IBD 72
Risk factors for depression and anxiety in Crohn's disease 71
Biosimilars of Adalimumab in Inflammatory Bowel Disease: Are we Ready for that? 71
Abdominal pain after minor trauma in a patient with Crohn's disease 70
Accuracy of a New Fujiifilm Blue Light Prototype in Predicting the Histology of Subcentimetric Polyps 68
PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD 68
An Unusual Case of Cardiac Involvement in Crohn's Disease 68
JAK inhibitors in crohn’s disease: ready to go? 68
Cross-Sectional Imaging Instead of Colonoscopy in Inflammatory Bowel Diseases: Lights and Shadows 67
Use of biologics for the management of Crohn's disease: IG-IBD clinical guidelines based on the GRADE methodology 67
ASSESSMENT OF THE DISEASE EXTENSION IN CHILDREN AND ADOLESCENTS WITH IBD: COMPARISON OF BOWEL ULTRASOUND AND MAGNETIC RESONANCE ENTEROGRAPHY 66
Early Intestinal Ultrasound Predicts Long-Term Endoscopic Response to Biologics in Ulcerative Colitis 66
Psychological Functioning of Patients With Inflammatory Bowel Disease 66
Antibodies to infliximab in patients treated with either the reference biologic or the biosimilar CT-P13 show identical reactivity towards biosimilars CT-P13 and SB2 in inflammatory bowel disease 65
JAK inhibitors: Novel developments in management of ulcerative colitis 64
STIMULATION OF CYP450-MEDIATED omega-3 DOCOSAHEXAENOIC ACID (DHA) METABOLISM VIA MFSD2A AS A NOVEL THERAPY FOR INFLAMMATORY BOWEL DISEASE 62
Can IL-23 be a good target for ulcerative colitis? 62
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 62
Impact of SARS-CoV-2 Infection on the Course of Inflammatory Bowel Disease in Patients Treated with Biological Therapeutic Agents: A Case-Control Study 61
SWITCHING FROM INFLIXIMAB ORIGINATOR TO CT-P13 IS NOT RELATED TO INCREASED IMMUNOGENICITY IN IBD PATIENTS: A PROSPECTIVE CASE-CONTROL STUDY 61
Psychological Characteristics of Inflammatory Bowel Disease Patients: A Comparison Between Active and Nonactive Patients 61
Post-inflammatory Polyp Burden as a Prognostic Marker of Disease-outcome in Patients with Inflammatory Bowel Disease 60
BOWEL ULTRASOUND IS ACCURATE IN ASSESSING DISEASE ACTIVITY IN ULCERATIVE COLITIS 60
Incidence and Patterns of COVID-19 Among Inflammatory Bowel Disease Patients From the Nancy and Milan Cohorts 60
Janus kinase inhibitors for the treatment of inflammatory bowel diseases: developments from phase I and phase II clinical trials 59
Comparison of two methods for the in-vivo diagnosis of Helicobacter pylori infection using a tablet of C-13-urea 59
ECCO Topical Review on Biological Treatment Cycles in Crohn's Disease 58
Psychological factors and quality of life in inflammatory bowel diseases patients: the Psycho study 58
Early Ultrasound Response and Progressive Transmural Remission After Treatment With Ustekinumab in Crohn's Disease 57
Point-of-Care Ultrasound in Inflammatory Bowel Disease 57
Patient's profiling for therapeutic management of inflammatory bowel disease: a tailored approach 57
Transperineal perineal ultrasound versus magnetic resonance imaging in the assessment of perianal Crohn's disease 57
Outcome in ulcerative colitis after switch from adalimumab/golimumab to infliximab: A multicenter retrospective study 56
Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study 56
COMPARATIVE ACCURACY OF US VERSUS MRI AND COLONOSCOPY IN ASSESSING DISEASE ACTIVITY AND COMPLICATIONS AND INFLUENCING THE DECISION-MAKING PROCESS IN CROHN'S DISEASE 56
Infliximab discontinuation is associated with a higher risk for relapse in patients with ulcerative colitis in remission: a multinational collaborative retrospective study 55
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 54
Milan Ultrasound Criteria are accurate in assessing disease activity in ulcerative colitis: External validation 54
Efficacy of tumour necrosis factor antagonists in stricturing Crohn's disease: A tertiary center real-life experience 53
Improving quality of care in endoscopy of inflammatory bowel disease: can we do better? 53
Modulation of sphingosine-1-phosphate in ulcerative colitis 53
Totale 8.814
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.683
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.683
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202292 0 0 0 73 1 5 0 1 0 2 5 5
2022/2023252 149 36 9 2 1 25 10 9 8 2 0 1
2023/202461 1 3 2 0 4 16 3 6 0 0 2 24
2024/20251.881 106 8 13 3 1 56 134 295 357 495 147 266
2025/20268.996 663 597 505 1.065 765 320 751 676 2.170 470 539 475
2026/2027816 424 392 0 0 0 0 0 0 0 0 0 0
Totale 12.098